Biocon Ltd.’s consolidated web revenue fell 84.3% within the second quarter of fiscal 2025, lacking analysts’ estimates.
The drugmaker’s revenue declined to Rs 27.1 crore within the September quarter, as in comparison with Rs 172.7 crore within the year-ago interval, in response to an trade submitting on Wednesday. That compares with the Rs 24-crore consensus estimate of analysts tracked by Bloomberg.
This article was written byFollowFred Piard, PhD. is a quantitative analyst and IT professional with over 30 years of experience...
Last week Microsoft Israel, the local marketing and sales office of the US software giant, announced the departure of...
Mohit Malhotra, Global CEO, Dabur India Dabur India posted a consolidated net profit of ₹362 crore in the March quarter,...
Quick Read Jim Cramer said no to Applied Digital (APLD) despite its $7.5 billion CoreWeave contract, arguing the company is...
Kevin Warsh, U.S. President Donald Trump's pick to lead the Federal Reserve, cleared a key procedural hurdle on Wednesday, opening...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
